Landscape of phase 1 clinical trials for minors with cancer in the United States.
Jaclynne H NaderDylan V NeelDavid S ShulmanClement MaFlorence BourgeoisSteven G DuBoisPublished in: Pediatric blood & cancer (2020)
The paucity of clear temporal trends highlights the need for innovation in early drug development for young people. Our analysis serves as a benchmark against which to evaluate initiatives to improve pediatric cancer drug development.